Blue Trust’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.41K Buy
+28
New +$3.46K ﹤0.01% 1838
2025
Q4
– Sell
-11
Closed -$310 – 2728
2025
Q3
$310 Hold
11
– – ﹤0.01% 2479
2025
Q2
$405 Sell
11
-213
-95% -$7.36K ﹤0.01% 2337
2025
Q1
$8.79K Hold
224
– – ﹤0.01% 1949
2024
Q4
$10.4K Sell
224
-3,586
-94% -$162K ﹤0.01% 1828
2024
Q3
$188K Buy
3,810
+2,635
+224% +$125K ﹤0.01% 886
2024
Q2
$40.3K Buy
1,175
+1,136
+2,913% +$46.3K ﹤0.01% 1342
2024
Q1
$1.34K Sell
39
-211
-84% -$7.62K ﹤0.01% 1890
2023
Q4
$5K Buy
+250
New +$5.78K ﹤0.01% 1868
2023
Q2
– Sell
-7
Closed – – 2528
2023
Q1
$0 Sell
7
-129
-95% -$2.85K ﹤0.01% 2642
2022
Q4
$4K Buy
136
+54
+66% +$1.57K ﹤0.01% 1818
2022
Q3
$2K Buy
+82
New +$3.48K ﹤0.01% 1838

Other funds holding TWST

Blue Trust's TWST Position: Q3 2026 in Review

Blue Trust opened a new position in Twist Bioscience (TWST) in Q3 2026: 28 shares worth $5.41K. The stake represents ﹤0.01% of the portfolio and ranks #1838 among its holdings. This is a return to the name: Blue Trust previously reported a position in TWST as recently as Q3 2025.

Blue Trust first reported a position in TWST in Q3 2022 and has held it in 12 quarters since. The position peaked at $188K in Q3 2024. 355 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Blue Trust held 28 shares of Twist Bioscience worth $5.41K as of Q3 2026.
  • Twist Bioscience was a new Blue Trust position in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1838 holding.
  • Blue Trust first reported a position in Twist Bioscience in Q3 2022 and has held it in 12 quarters since.
  • Blue Trust's Twist Bioscience position peaked at $188K in Q3 2024.
  • 355 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.